Diagnosing Hope: Top 10 Companies in the Europe Cancer Diagnostics Market

The Europe Cancer Diagnostics Market will grow at a CAGR of 5.6% during the forecast period to reach $12.21 billion by 2031. Cancer diagnosis comprises a number of in vitro diagnostics and imaging tests used to diagnose different kinds of cancer, such as breast cancer, lung cancer, prostate cancer, colorectal cancer, and other cancer types. These tests are used to identify any indication of cancer, guide treatment decisions, predict the risk of cancer recurrence, track treatment effectiveness, and characterize its type and stage. This report provides a market assessment of products used for cancer diagnosis, which includes kits & reagents, imaging instruments, and IVD instruments, among others.